ClinVar Miner

Submissions for variant NM_020975.6(RET):c.166C>A (p.Leu56Met) (rs145633958)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 18
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000121985 SCV000113984 benign not specified 2014-06-19 criteria provided, single submitter clinical testing
Ambry Genetics RCV000163266 SCV000213794 benign Hereditary cancer-predisposing syndrome 2015-01-27 criteria provided, single submitter clinical testing Subpopulation frequency in support of benign classification;Other strong data supporting benign classification;In silico models in agreement (benign);Other data supporting benign classification;Co-occurence with a mutation in another gene that clearly explains a proband's phenotype
Division of Genomic Diagnostics,The Children's Hospital of Philadelphia RCV000202649 SCV000258169 benign Multiple endocrine neoplasia 2015-06-25 criteria provided, single submitter clinical testing
Invitae RCV001082759 SCV000261742 benign Multiple endocrine neoplasia, type 2 2019-12-31 criteria provided, single submitter clinical testing
GeneDx RCV000121985 SCV000514406 likely benign not specified 2018-01-03 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000121985 SCV000711342 likely benign not specified 2016-04-20 criteria provided, single submitter clinical testing p.Leu56Met in exon 2 of RET: This variant is not expected to have clinical signi ficance because it has been identified in 0.4% (271/66206) of European chromosom es, including 1 homozygote by the Exome Aggregation Consortium (ExAC, http://exa c.broadinstitute.org; dbSNP rs145633958).
PreventionGenetics,PreventionGenetics RCV000121985 SCV000807009 benign not specified 2016-10-10 criteria provided, single submitter clinical testing
Mendelics RCV000030402 SCV001138019 benign Multiple endocrine neoplasia, type 2a 2019-05-28 criteria provided, single submitter clinical testing
CeGaT Praxis fuer Humangenetik Tuebingen RCV000034766 SCV001147859 likely benign not provided 2019-11-01 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV000121985 SCV001158030 likely benign not specified 2018-08-12 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000202649 SCV001266132 benign Multiple endocrine neoplasia 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.
Illumina Clinical Services Laboratory,Illumina RCV001108849 SCV001266133 likely benign Renal hypodysplasia/aplasia 1 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Illumina Clinical Services Laboratory,Illumina RCV001108850 SCV001266134 uncertain significance Pheochromocytoma 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Illumina Clinical Services Laboratory,Illumina RCV001108851 SCV001266135 likely benign Hirschsprung disease 1 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Biesecker Lab/Clinical Genomics Section,National Institutes of Health RCV000034766 SCV000043467 no known pathogenicity not provided 2012-07-13 no assertion criteria provided research Converted during submission to Benign.
Integrated Genetics/Laboratory Corporation of America RCV000030402 SCV000053071 benign Multiple endocrine neoplasia, type 2a 2012-03-13 no assertion criteria provided clinical testing
ITMI RCV000121985 SCV000086196 not provided not specified 2013-09-19 no assertion provided reference population
CSER _CC_NCGL, University of Washington RCV000148768 SCV000190505 likely benign Hirschsprung disease 2014-06-01 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.